RATIONALE: Peanut oral immunotherapy (OIT) is a promising treatment to desensitize peanut allergic patients. Our aim was to identify and assess changes in IgE and IgG4 epitopes of the major peanut allergens, Ara h 1, 2, 3, and 6, recognized by peanut allergic patients undergoing peanut OIT in the US. METHODS: Microarray slides containing synthetic overlapping 15-mer peptides offset by 5 aa of the major peanut allergens, Ara h 1, 2, 3, and 6, were incubated with sera from 27 peanut allergic patients from the US enrolled in Phase 2 and Phase 3 peanut OIT trials. The pre-trial and posttrial sera were collected between 5 months to a year apart, and were tested for IgE and IgG4 binding to the linear peptides using immunofluorescence. RESULTS: IgE and IgG4 epitope maps for the four major peanut allergens were developed. While IgE binding patterns to the immunodominant epitopes (recognized by >70% of the sera) for each allergen did not seem to change much, there was significant changes in the intensity of the antibody binding for a majority of patient sera. Also, the peptide-specific IgE/IgG4 immunofluorescence ratios from pre-trial sera were higher than the posttrial sera. CONCLUSIONS: These results demonstrated that peanut OIT induces a shift in the IgE/IgG4 peptide-binding ratios in peanut allergic sera, but does not seem to alter the actual peptide binding patterns significantly after 1 year of OIT. This type of knowledge can be useful in the identification of peptide biomarkers that may indicate desensitization or tolerance of allergic individuals to peanut.
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The 1 Yale University School of Medicine, Yale New Haven Health, New Haven, CT, 2 Yale University School of Medicine, New Haven, CT. RATIONALE: Prior studies indicate that walnut component testing (WCT) may serve as a better indicator for clinical reactivity than skin prick (SPT) and walnut-specific IgE testing (wIgE) in patients with birch pollen allergy. The efficacy of WCT in determining clinical reactivity represents a potential gap in clinical management. METHODS: A retrospective chart review was performed on four patients who underwent WCT to rJug r 1 and 3. None of the patients ate products containing walnuts (PCW) at the time of WCT due to prior positive allergy testing with wIgE testing. Three of the patients reported tolerating PCW prior to allergy testing and one developed throat itching upon ingestion. The charts were reviewed for demographic data, birch specific IgE (bIgE), wIgE levels, walnut rJug r 1 and 3 levels, and a trial of PCW. RESULTS: Average total IgE5660 (SD: 517.25; N54), bIgE59.58 (SD57.41; N54), wIgE50.49 (SD50.13; N54). Both walnut rJug r 1 and 3 were reported as <0.10 in each of the patients. All four patients tolerated walnuts during in-office or home challenge. CONCLUSIONS: This was a pilot study undertaken to investigate the utility of WCT. This study suggests that WCT can determine clinical reactivity in birch pollen allergic patients with positive wIgE. RATIONALE: Fenugreek (Trigonella foenum-graecum ) is a legume plant traditionally used as spice in Indian-style foods. Although it has been used since ancient times, its allergenicity has only been reported in the last two decades, often as hidden allergen, in peanut allergic patients. METHODS: A 10-year-old girl, with known peanut allergy was refered to our unit with a history of severe anaphilaxys after eating curried chicken. Skin prick testing (SPT) and sIgE measurements (ImmunoCAP Thermofisher Ò) were performed with the implicated curry and its components and peanut. IgE -binding-protein molecular mass study (SDS-PAGE-Immunobloting) was also performed with the curry powder and its ingredients, fenugreek (grains and powder) and a whole extract of roasted peanut. Immunoblotting inhibition studies were also carried out. RESULTS: SPT were positive to peanut (13 mm), curry powder (18.5 mm), fenugreek (23 mm). The diameter of the wheal on SPT with the remaining spices contained in curry was less than the histamine control. Specific IgE: peanut >100 KU/L, curry 35.20 KU/L, fenugreek 45 KU/L, Ara h 2 >100 KU/L. SDS-PAGE-Immunoblotting: The peanut protein band pattern was in accordance with previous studies. Curry and Fenugreek extract showed similar pattern: IgE-binding bands 50, 28 and 22 kDa (same molecular mass bands are observed in peanut pattern). Cross-reactivity study with curry and fenugreek extract as solid phase: peanut extract inhibited completely IgE binding to fenugreek and curry extract. CONCLUSIONS: Cross reactivity between peanut and fenugreek is demonstrated. Physicians might be aware about possible curry allergy in peanut-allergic patients.
Beef Sensitization in Pediatric Patients in the Midwest
Salman A. Aljubran, MD 1 , and Charles S. Barnes, PhD FAAAAI 2 ; 1 Broadway Clinics, Children's Mercy Hospital and Clinics, Kansas, MO, 2 Children Mercy Hospital, kansas city, MO. RATIONALE: Food allergy is on the rise. It is estimated that 8% of children and 6% of adults have food allergies. It is about 3-15% of pediatric patients have meat allergy. Beef allergy is the most reported one among meat allergy. It can reach up to 6.5 % in atopic dermatitis pediatric patients. The aim is to assess the sensitization rate to beef in pediatric patient in the Midwest. METHODS: Laboratory results of 483,490 specific IgE evaluations were reviewed to identify patients with positive IgE to beef. IgE determinations were performed from the year 2000 to 2015 on pediatric patients, ages 0.5 to 18 years, using the ThermoFisher ImmunoCap instrument. A test was considered positive when specific IgE values were greater than 0.35 kU/L. RESULTS: 509 individual patients were identified. Of those, 128 (25%) patients had positive IgE to beef; 86 (67%) were male while 42 (32%) were female. CONCLUSIONS: The prevalence of beef sensitization in pediatric patients in the Midwest of the US is similar to previously reported in the literature. Allergist need to be aware of beef allergy since beef is not one of the eight major food allergens in pediatric patients.
